These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 2153095)

  • 21. Pulmonary accumulation of amiodarone and N-desethylamiodarone. Relationship to the development of pulmonary toxicity.
    Wilson BD; Lippmann ML
    Am Rev Respir Dis; 1990 Jun; 141(6):1553-8. PubMed ID: 2350098
    [TBL] [Abstract][Full Text] [Related]  

  • 22. X-ray microanalysis of cultured alveolar macrophages with phospholipidosis.
    Lee P; Kirk RG; Reasor MJ
    Exp Mol Pathol; 1993 Apr; 58(2):96-104. PubMed ID: 8388333
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Repeated amiodarone exposure in the rat: toxicity and effects on hepatic and extrahepatic monooxygenase activities.
    Daniels JM; Leeder RG; Brien JF; Massey TE
    Can J Physiol Pharmacol; 1990 Sep; 68(9):1261-8. PubMed ID: 2276089
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The role of CYP 3A4 and 1A1 in amiodarone-induced hepatocellular toxicity.
    Wu Q; Ning B; Xuan J; Ren Z; Guo L; Bryant MS
    Toxicol Lett; 2016 Jun; 253():55-62. PubMed ID: 27113703
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Basic and clinical pharmacology of amiodarone: relationship of antiarrhythmic effects, dose and drug concentrations to intracellular inclusion bodies.
    Somani P
    J Clin Pharmacol; 1989 May; 29(5):405-12. PubMed ID: 2544634
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Anti-arrhythmic effects of amiodarone and desethylamiodarone on malignant ventricular arrhythmias arising as a consequence of ischaemia and reperfusion in the anaesthetised rat.
    Riva E; Hearse DJ
    Cardiovasc Res; 1989 Apr; 23(4):331-9. PubMed ID: 2590914
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pulmonary fibrosis induced in the hamster by amiodarone and desethylamiodarone.
    Daniels JM; Brien JF; Massey TE
    Toxicol Appl Pharmacol; 1989 Sep; 100(2):350-9. PubMed ID: 2781562
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Peripheral neutrophil inclusions in amiodarone treated patients.
    Adams PC; Sloan P; Morley AR; Holt DW
    Br J Clin Pharmacol; 1986 Dec; 22(6):736-8. PubMed ID: 3032227
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Interaction of amiodarone and desethylamiodarone with solubilized nuclear thyroid hormone receptors.
    Latham KR; Sellitti DF; Goldstein RE
    J Am Coll Cardiol; 1987 Apr; 9(4):872-6. PubMed ID: 3558985
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmacodynamic studies of amiodarone and its active N-desethyl metabolite.
    Nattel S
    J Cardiovasc Pharmacol; 1986; 8(4):771-7. PubMed ID: 2427817
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tissue distribution of amiodarone and desethylamiodarone in rats after multiple intraperitoneal administration of various amiodarone dosages.
    Plomp TA; Wiersinga WM; Maes RA
    Arzneimittelforschung; 1985; 35(1):122-9. PubMed ID: 4039141
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of amiodarone on the phospholipid and lamellar body content of lymphoblasts in vitro and peripheral blood lymphocytes in vivo.
    Hostetler KY; Vande Berg J; Aldern KA; Brophy GT
    Biochem Pharmacol; 1991 Mar 15-Apr 1; 41(6-7):1007-13. PubMed ID: 1848974
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Influence of a pre-existing phospholipidosis on the accumulation of amiodarone and desethylamiodarone in rat alveolar macrophages.
    Reasor MJ
    Res Commun Chem Pathol Pharmacol; 1991 May; 72(2):169-81. PubMed ID: 1876748
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Modulation of protein kinase C activity by amiodarone and desethylamiodarone.
    Vig PJ; Desaiah D
    Neurotoxicology; 1991; 12(3):595-601. PubMed ID: 1745442
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Amiodarone and desethylamiodarone tissue uptake in rats chronically treated with amiodarone is non-linear with the dose.
    Latini R; Bizzi A; Cini M; Veneroni E; Marchi S; Riva E
    J Pharm Pharmacol; 1987 Jun; 39(6):426-31. PubMed ID: 2886599
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Relationship of steady-state serum concentrations of amiodarone and desethylamiodarone to therapeutic efficacy and adverse effects.
    Falik R; Flores BT; Shaw L; Gibson GA; Josephson ME; Marchlinski FE
    Am J Med; 1987 Jun; 82(6):1102-8. PubMed ID: 3605129
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmacokinetics of amiodarone, desethylamiodarone and other iodine-containing amiodarone metabolites.
    Stäubli M; Troendle A; Schmid B; Balmer P; Kohler B; Studer H; Bircher J
    Eur J Clin Pharmacol; 1985; 29(4):417-23. PubMed ID: 4092724
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cytotoxicity evaluation after coexposure to perchloroethylene and selected peroxidant drugs in rat hepatocytes.
    Costa C; Barbaro M; Catania S; Silvari V; Germanò MP
    Toxicol In Vitro; 2004 Feb; 18(1):37-44. PubMed ID: 14630060
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacokinetics and body distribution of amiodarone and desethylamiodarone in rats after intravenous administration.
    Plomp TA; Wiersinga WM; van Rossum JM; Maes RA
    In Vivo; 1989; 3(1):33-47. PubMed ID: 2519831
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Amiodarone and desethylamiodarone concentrations in plasma and tissues of surgically treated patients on long-term oral amiodarone treatment.
    Plomp TA; Hauer RN; Robles de Medina EO
    In Vivo; 1990; 4(2):97-100. PubMed ID: 2129806
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.